AzTrials
AzTrials

Sleep QualityNeo-SIPaSNCT03004677

Effect of Skin-to-skin Contact on Interaction and Parents' Sleep

A study testing Continuous skin-to-skin contact in people with Sleep Quality and Communication, run by Linkoeping University at 3 sites in Sweden.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This study evaluates the effect of a late intervention of continuous skin-to-skin contact (SSC) in the neonatal intensive care unit (NICU). Half of the participants will receive the intervention and the other half will receive standard care. Read more about this study

Who is it for?
Any age
Conditions the study is for
Sleep Quality, Communication, Stress Reaction
What is being tested?
Continuous skin-to-skin contact
Could I receive a placebo?
No, everyone receives an active treatment
How many people
11 participants
Where
3 sitesSweden
Study dates
Jan 2017to 31 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Parents staying at the NICU with a single preterm infant born <33 weeks of gestation
  • The family should have been transferred to family-room from intensive care
  • Swedish speaking parents

Who cannot join

  • Infants with major congenital malformation,
  • Infants with intraventricular hemorrhage grade III-IV
  • Infants with chromosome defect that could affect the infant´s ability to interact.
  • Parents with sleeping disorder
  • Parents with psychiatric problem or drug use.

Trial locations and contacts

3 sites in 1 country.

Sweden3 sites
  • University Hospital

    Linköping

  • University hospital Örebro

    Örebro

  • Uppsala University Hospital

    Uppsala

Other trials in Sweden

About this study

This study evaluates the effect of a late intervention of continuous skin-to-skin contact (SSC) in the neonatal intensive care unit (NICU). Half of the participants will receive the intervention and the other half will receive standard care.

Read the detailed description

The intervention is based on a method developed to facilitate closeness and human touch between parents and preterm infants in neonatal intensive care. Continuous skin-to-skin contact (SSC) means, in this study, that the late preterm infant is cared for skin-to-skin on the parents' chest, instead of in a heating-bed, 24 hours a day. The parents will take turns to care for the infant in SSC.

Being tested
Continuous skin-to-skin contact, Standard Care
Medical subject headings
Sleep Initiation and Maintenance Disorders, Communication, Fractures, Stress

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Continuous skin-to-skin contactBehavioural

    Infants will rest in skin-to-skin contact on parents' chest 24 hours a day alternating between the parents. The parents will note who provides the SSC and if and for how long they are off SSC for any reason.

  • Standard CareOther

    Infants will receive regular care in the NICU. Parents may practice SSC if they like. Parents will note if, with whom, and for how long they provide SSC.

Study groups in NCT03004677
Study groupRoleWhat they receive
Continuous skin-to-skin contactExperimentalInfants assigned to SSC will rest skin-to-skin on parents' chest 24 hours a day for four days alternating between the parents.
Receives: Behavioral: Continuous skin-to-skin contact
Standard CareActive comparatorInfants and parents will receive standard care provided in the NICU
Receives: Other: Standard Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sleep quality

    sleep diary every day for five days

    Measured: Day 1 to 5

Secondary outcomes (5)
  1. Mood

    Mood Adjective Checklist (MACL)

    Measured: day 2 to 5

  2. Bonding

    Mother to Infant Bonding Scale (MIBS)

    Measured: Baseline and 1-3 days before planned discharge from the NICU.

  3. Depression

    The Edinburgh Postnatal Depression Scale, EPDS

    Measured: Baseline and 1-3 days before planned discharge from the NICU.

  4. Anxiety

    State Trait Anxiety Inventory, STAI

    Measured: Baseline and 1-3 days before planned discharge from the NICU.

  5. Activity

    Actigraph every day for five days

    Measured: Day 1-5

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Dec 2016 (estimated)
  2. Study startJan 2017
  3. Primary completion31 Dec 2019
  4. Study completion31 Dec 2019

Why it stopped: To difficult to recruit.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
11 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03004677
Sponsor's protocol ID
Linkoeping University
Acronym
Neo-SIPaS
Status last verified
Mar 2020
First submitted
10 Dec 2016
Last updated
4 Mar 2020
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Morelius E, Olsson E, Sahlen Helmer C, Thernstrom Blomqvist Y, Angelhoff C. External barriers for including parents of preterm infants in a randomised clinical trial in the neonatal intensive care unit in Sweden: a descriptive study. BMJ Open. 2020 Dec 4;10(12):e040991. doi: 10.1136/bmjopen-2020-040991.

    PubMed 33277288
  • Angelhoff C, Blomqvist YT, Sahlen Helmer C, Olsson E, Shorey S, Frostell A, Morelius E. Effect of skin-to-skin contact on parents' sleep quality, mood, parent-infant interaction and cortisol concentrations in neonatal care units: study protocol of a randomised controlled trial. BMJ Open. 2018 Aug 1;8(7):e021606. doi: 10.1136/bmjopen-2018-021606.

    PubMed 30068615

Questions about this trial

What is this clinical trial studying?

A study testing Continuous skin-to-skin contact in people with Sleep Quality and Communication, run by Linkoeping University at 3 sites in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 4 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: To difficult to recruit.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sleep quality (time frame: Day 1 to 5). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03004677, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in